Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lanctôt

Showing results (11-20 of 360) with videos related to

Pageof 36
Sort By:
The Journal of Neuropsychiatry and Clinical Neurosciences|February 24, 2001
Role of serotonin in the behavioral and psychological symptoms of dementiaK L Lanctôt, N Herrmann, P Mazzotta
The American Journal of Psychiatry|June 1, 2004
Atypical antipsychotics and risk of cerebrovascular accidentsNathan Herrmann, Muhammad Mamdani, Krista L Lanctôt
Expert Opinion on Drug Safety|September 1, 2004
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's diseaseSarah Thompson, Krista L Lanctôt, Nathan Herrmann
Journal of Affective Disorders|February 13, 2017
Ceramides and depression: A systematic reviewAdam Dinoff, Nathan Herrmann, Krista L Lanctôt
Expert Review of Respiratory Medicine|October 13, 2015
Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for preventionHaben Y Abraha, Krista L Lanctôt, Bosco Paes
Current Drug Targets|September 25, 2010
Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelaeA B Gold, N Herrmann, K L Lanctôt
Therapeutic Advances in Neurological Disorders|December 24, 2010
Therapy for Alzheimer's Disease: How Effective are Current Treatments?Krista L Lanctôt, Ryan D Rajaram, Nathan Herrmann
Journal of Psychiatry & Neuroscience : JPN|February 18, 2003
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Maysoon M LouLou
Journal of Medical Economics|September 29, 2012
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidenceJ M Hussman, K L Lanctôt, B Paes
Alzheimer'S Research & Therapy|February 26, 2014
Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012Nathan Herrmann, Krista L Lanctôt, David B Hogan
Pageof 36

Showing results (11-20 of 360) with videos related to

Sort By:
Pageof 36
The Journal of Neuropsychiatry and Clinical Neurosciences|February 24, 2001
Role of serotonin in the behavioral and psychological symptoms of dementiaK L Lanctôt, N Herrmann, P Mazzotta
The American Journal of Psychiatry|June 1, 2004
Atypical antipsychotics and risk of cerebrovascular accidentsNathan Herrmann, Muhammad Mamdani, Krista L Lanctôt
Expert Opinion on Drug Safety|September 1, 2004
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's diseaseSarah Thompson, Krista L Lanctôt, Nathan Herrmann
Journal of Affective Disorders|February 13, 2017
Ceramides and depression: A systematic reviewAdam Dinoff, Nathan Herrmann, Krista L Lanctôt
Expert Review of Respiratory Medicine|October 13, 2015
Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for preventionHaben Y Abraha, Krista L Lanctôt, Bosco Paes
Current Drug Targets|September 25, 2010
Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelaeA B Gold, N Herrmann, K L Lanctôt
Therapeutic Advances in Neurological Disorders|December 24, 2010
Therapy for Alzheimer's Disease: How Effective are Current Treatments?Krista L Lanctôt, Ryan D Rajaram, Nathan Herrmann
Journal of Psychiatry & Neuroscience : JPN|February 18, 2003
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Maysoon M LouLou
Journal of Medical Economics|September 29, 2012
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidenceJ M Hussman, K L Lanctôt, B Paes
Alzheimer'S Research & Therapy|February 26, 2014
Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012Nathan Herrmann, Krista L Lanctôt, David B Hogan
Pageof 36